Greater Cannabis Company (GCAN) Retained Earnings (2016 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Retained Earnings of -$5.0 million in Q1 2026, down 0.67% quarter-over-quarter from -$5.0 million in Q4 2025, and down 2.5% on a YoY basis from -$5.2 million in Q1 2025.
Greater Cannabis Company (GCAN) Retained Earnings (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Retained Earnings history runs 11 years deep, the most recent figure standing at -$5.0 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 2.5% year-over-year to -$5.0 million; the TTM figure through Mar 2026 stood at -$5.0 million (down 2.5% YoY), while the FY2025 annual figure was -$5.0 million, down 7.12% from the prior year.
- Retained Earnings was -$5.0 million for Q1 2026 at Greater Cannabis Company, down from -$5.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$4.1 million in Q1 2022 to a low of -$5.3 million in Q3 2025.
- Historically, Retained Earnings has averaged -$4.6 million across 5 years, with a median of -$4.5 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings retreated 18.91% in 2022, then decreased 2.5% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$4.3 million in 2022, then retreated by 4.39% to -$4.5 million in 2023, then decreased by 4.0% to -$4.7 million in 2024, then dropped by 7.12% to -$5.0 million in 2025, then retreated by 0.67% to -$5.0 million in 2026.
- The last three Retained Earnings figures came in at -$5.0 million (Q1 2026), -$5.0 million (Q4 2025), and -$5.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Greater Cannabis Company | - | - | - | -5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.03 Mn |
| Dec 31, 2025 | -4.99 Mn |
| Sep 30, 2025 | -5.33 Mn |
| Jun 30, 2025 | -5.29 Mn |
| Mar 31, 2025 | -4.90 Mn |
| Dec 31, 2024 | -4.66 Mn |
| Sep 30, 2024 | -4.62 Mn |
| Jun 30, 2024 | -4.57 Mn |
| Mar 31, 2024 | -4.53 Mn |
| Dec 31, 2023 | -4.48 Mn |
| Sep 30, 2023 | -4.43 Mn |
| Jun 30, 2023 | -4.38 Mn |
| Mar 31, 2023 | -4.34 Mn |
| Dec 31, 2022 | -4.29 Mn |
| Sep 30, 2022 | -4.25 Mn |
| Jun 30, 2022 | -4.14 Mn |
| Mar 31, 2022 | -4.08 Mn |
| Dec 31, 2021 | -3.93 Mn |
| Sep 30, 2021 | -3.74 Mn |
| Jun 30, 2021 | -3.48 Mn |